ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,250Medicare Part D Prescriptions Filled, Including Refills

Rank: 302 out of 1111

$600K Total Retail Price of All Prescriptions

Rank: 147 out of 1111

329 Patients Receiving at Least One Drug in Part D
57%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 329 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 329 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 4,207 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$83 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 305 168 S3 1 1
LEVOTHYROXINE SODIUM 276 207 2 3
OMEPRAZOLE 224 101 3 4
LISINOPRIL 208 132 4 2
HYDROCHLOROTHIAZIDE 177 127 5 11
METFORMIN HCL 175 118 6 8
ALENDRONATE SODIUM 149 130 7 35
PRAVASTATIN SODIUM 141 91 8 17
SIMVASTATIN 106 84 9 5
ZOLPIDEM TARTRATE 104 53 10 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 102 51 11 23
CITALOPRAM HBR 101 46 12 14
BYSTOLIC 96 64 13 133
WARFARIN SODIUM 91 65 14 19
FLUTICASONE PROPIONATE 88 53 15 27
LYRICA 85 29 16 62
FUROSEMIDE 84 47 17 6
LOSARTAN POTASSIUM 80 57 18 34
PEN NEEDLE 78 36 19 207
NEXIUM 77 42 20 26
ENALAPRIL-HYDROCHLOROTHIAZIDE 74 56 21 284
PAROXETINE HCL 74 36 21 55
METOPROLOL TARTRATE 72 49 23 12
POTASSIUM CHLORIDE 67 39 24 9
TRAMADOL HCL 66 21 25 13
AMLODIPINE BESYLATE 64 59 26 7
GABAPENTIN 64 24 26 10
CARVEDILOL 60 22 28 21
ROPINIROLE HCL 60 22 28 68
LANTUS SOLOSTAR 57 29 30 135
ATORVASTATIN CALCIUM 57 44 30 15
CYMBALTA 55 32 32 40
ENALAPRIL MALEATE 55 33 32 56
LOVAZA 55 17 32 184
ADVAIR DISKUS 54 38 35 43
PANTOPRAZOLE SODIUM 54 28 35 50
CYCLOBENZAPRINE HCL 53 18 R 37 37
METFORMIN HCL ER 53 32 37 84
AMITRIPTYLINE HCL 52 17 R 39 64
NAPROXEN 52 23 39 85
SERTRALINE HCL 51 49 41 24
DIOVAN HCT 50 44 42 94
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.